Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Centese

Explore full profile

Develops cardiothoracic post-operative medical equipment for post-operative surgical care and patient monitoring

Omaha, United StatesFounded 2015Health Tech & Medtech
Valuation <$5M Last recorded · 2026
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Centese and the history behind them.

About Centese

Centese Inc. is a medical technology company specializing in advanced digital solutions for cardiothoracic surgery. Their flagship product, Thoraguard, revolutionizes post-operative care by providing precise data monitoring and automated chest tube clearance. This innovation aims to enhance clinical decision-making and patient safety, ultimately improving outcomes and reducing costs. Centese serves healthcare providers and hospitals in the cardiothoracic surgery market. Their business model revolves around selling and supporting their digital systems, generating revenue through product sales and service contracts.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Omaha, United States
Employees
17
Open positions
None listed
Dealroom signal
75.4/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Surgery, Critical medical care, Hard Tech, remote health monitoring, DT and LS, science-based
Technology
Deep Tech
Client focus
b2b

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Nov 2023 $15M $60M MedTech VP ↗
SERIES A✓Equity / VC Aug 2019 $2M $8M Invest Nebraska —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Centese website traffic

Latest recorded traffic for Centese is 220 monthly website visits, down 63.3% over the last three months. Centese's team grew 0% over the past year.

Latest monthly visits220 3-month web change-63.3% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US National Science Foundation

Series A2 investors entered at this stage

  • Invest Nebraska
  • MedTech VP

Other known investors8 additional known investors

  • Brock Smith
  • Innovation In Motion
  • Nebraska Angel Network
  • New York Angels
  • Nucleate
  • Proven Ventures
  • Scientific Health Development Partners
  • The Startup Collaborative
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Centese on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Centese’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.